DNA - Ginkgo Bioworks Holdings, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Ginkgo Bioworks Holdings, Inc.
IPO Date: September 17, 2021
Sector: Healthcare
Industry: Biotech
Market Cap: $772.39M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.29 | 4.90%
Avg Daily Range (30 D): $0.55 | 5.44%
Avg Daily Range (90 D): $0.39 | 4.35%
Institutional Daily Volume
Avg Daily Volume: 14.07M
Avg Daily Volume (30 D): 2.33M
Avg Daily Volume (90 D): 1.48M
Trade Size
Avg Trade Size (Sh.): 471
Avg Trade Size (Sh.) (30 D): 101
Avg Trade Size (Sh.) (90 D): 87
Institutional Trades
Total Institutional Trades: 2,431
Avg Institutional Trade: $1.73M
Avg Institutional Trade (30 D): $1.46M
Avg Institutional Trade (90 D): $1.24M
Avg Institutional Trade Volume: .04M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $2.42M
Avg Closing Trade (30 D): $1.51M
Avg Closing Trade (90 D): $1.26M
Avg Closing Volume: 68.82K
 
News
Oct 7, 2026 @ 9:15 PM
Ginkgo Bioworks Holdings, Inc. (DNA) Falls More St...
Source: Zacks.Com
Sep 24, 2026 @ 2:56 PM
AI-Driven Innovation Reshapes Vaccine Adjuvant Dis...
Source: Bcc Research
Sep 23, 2026 @ 10:15 PM
Ginkgo Bioworks Holdings, Inc. (DNA) Sees a More S...
Source: Zacks.Com
Sep 16, 2026 @ 10:15 PM
Ginkgo Bioworks Holdings, Inc. (DNA) Rises As Mark...
Source: Zacks.Com
Jun 28, 2026 @ 3:30 PM
Palantir's Bold Biosecurity Opportunity Could Be B...
Source: Rick Orford
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-5.01 $-.75 $-1.39
Diluted EPS
Revenue $111.86M $20.16M $19.47M
Gross Profit $18.44M $16.38M
Net Income / Loss $-290.8M $-46.71M $-82.59M
Operating Income / Loss $-290.69M $-58.55M $-71.37M
Cost of Revenue $1.72M $3.1M
Net Cash Flow $-79.34M $-16.65M $-23.7M
PE Ratio    
Splits
Aug 20, 2024 1:40